These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 18955948

  • 1. Cardiovascular safety of ADHD medication treatments.
    Newcorn JH.
    CNS Spectr; 2008 Oct; 13(10 Suppl 15):5-8. PubMed ID: 18955948
    [No Abstract] [Full Text] [Related]

  • 2. [Medication for ADHD and the risk of cardiovascular mortality].
    Kalverdijk LJ, Buitelaar JK, van der Gaag RJ.
    Ned Tijdschr Geneeskd; 2006 Oct 14; 150(41):2283-4; author reply 2284. PubMed ID: 17078147
    [No Abstract] [Full Text] [Related]

  • 3. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M.
    Pediatrics; 2007 Jan 14; 119(1):154-5. PubMed ID: 17200281
    [No Abstract] [Full Text] [Related]

  • 4. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH, Donnelly C.
    Mt Sinai J Med; 2009 Apr 14; 76(2):198-203. PubMed ID: 19306385
    [No Abstract] [Full Text] [Related]

  • 5. Stimulants and sudden death: what is a physician to do?
    Wilens TE, Prince JB, Spencer TJ, Biederman J.
    Pediatrics; 2006 Sep 14; 118(3):1215-9. PubMed ID: 16951018
    [Abstract] [Full Text] [Related]

  • 6. Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine.
    Biederman J, Spencer TJ, Wilens TE, Prince JB, Faraone SV.
    J Am Acad Child Adolesc Psychiatry; 2006 Oct 14; 45(10):1147-1150. PubMed ID: 16840880
    [No Abstract] [Full Text] [Related]

  • 7. Encouraging news about ADHD drugs and heart risk in adults.
    Harv Ment Health Lett; 2012 Mar 14; 28(9):7. PubMed ID: 22474711
    [No Abstract] [Full Text] [Related]

  • 8. ECGs before stimulants in children.
    Med Lett Drugs Ther; 2008 Jul 28; 50(1291):60. PubMed ID: 18654112
    [No Abstract] [Full Text] [Related]

  • 9. [Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate].
    Bange F, Le Heuzey MF, Acquaviva E, Delorme R, Mouren MC.
    Arch Pediatr; 2014 Jan 28; 21(1):108-12. PubMed ID: 24309201
    [Abstract] [Full Text] [Related]

  • 10. [Joint position of the Guideline Group of the European Network for Hyperkintetic Disorders (EUNETHYDIS) and the German Central ADHD Network for ECG Recording on methylphenidate prescriptions].
    Banaschewski T, EUNETHYDIS Guidelines Group.
    Z Kinder Jugendpsychiatr Psychother; 2008 Nov 28; 36(6):437-9. PubMed ID: 19034859
    [No Abstract] [Full Text] [Related]

  • 11. ADHD update: new data on the risks of medication.
    Harv Ment Health Lett; 2006 Oct 28; 23(4):3-5. PubMed ID: 17183739
    [No Abstract] [Full Text] [Related]

  • 12. Medications for attention deficit hyperactivity disorder: cardiovascular concerns.
    Wooltorton E.
    CMAJ; 2006 Jul 04; 175(1):29. PubMed ID: 16772535
    [No Abstract] [Full Text] [Related]

  • 13. Attention-deficit hyperactivity disorder (ADHD) treatment and sudden death.
    Besag FM.
    Drug Saf; 2009 Jul 04; 32(11):1097-100. PubMed ID: 19810781
    [No Abstract] [Full Text] [Related]

  • 14. Attention deficit hyperactivity disorder medications in children with heart disease.
    Berger S.
    Curr Opin Pediatr; 2016 Oct 04; 28(5):607-12. PubMed ID: 27261563
    [Abstract] [Full Text] [Related]

  • 15. Stimulants for kids with ADHD--how to proceed safely.
    Ken Mehta S, Jacobs I.
    J Fam Pract; 2014 Feb 04; 63(2):E1-5. PubMed ID: 24527478
    [Abstract] [Full Text] [Related]

  • 16. [Cardiovascular risk assessment for the use of ADHD drugs in children].
    Berg A, Bråtane E, Odland HH, Brudvik C, Rosland B, Hirth A.
    Tidsskr Nor Laegeforen; 2014 Apr 08; 134(7):710-4. PubMed ID: 24721858
    [Abstract] [Full Text] [Related]

  • 17. Stimulant treatment of ADHD and risk of sudden death in children.
    Vitiello B, Towbin K.
    Am J Psychiatry; 2009 Sep 08; 166(9):955-7. PubMed ID: 19528196
    [No Abstract] [Full Text] [Related]

  • 18. [Medication for ADHD and the risk of cardiovascular mortality].
    Langendijk PN, Wilde AA.
    Ned Tijdschr Geneeskd; 2006 Aug 05; 150(31):1713-4. PubMed ID: 16924941
    [Abstract] [Full Text] [Related]

  • 19. ADHD pharmacotherapy: rates of stimulant use and cardiovascular risk.
    Kratochvil CJ.
    Am J Psychiatry; 2012 Feb 05; 169(2):112-4. PubMed ID: 22318789
    [No Abstract] [Full Text] [Related]

  • 20. Management of a hyperactive teen and cardiac safety.
    Sowinski H, Karpawich PP.
    Pediatr Clin North Am; 2014 Feb 05; 61(1):81-90. PubMed ID: 24267459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.